Discover how AI and automation tools transform how we manage TMF content when it comes to identifying patient-centric risks.
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
- How The FDA, MHRA, & EMA Differ On Externally Controlled Trials
- What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't
- SCDM 2025: Practical Advice From Global Regulators — Including The FDA
- RWE Is Growing Up, And Here's Why That Matters
- Powering Standards With Code: The Role Of Open Source In CDISC 360i
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
OpenClinica EDC: Friendly & Easy to Deploy?
Find out how OpenClinica stands out in the global EDC landscape through its user-friendly interface, strong integration capabilities, and extensive partnerships.
-
Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them
Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.
-
It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies
CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.
-
Embracing Accessibility: The Future Of Clinical Trials
Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
-
Why Oncology Drug Development Lags In Digital Biomarkers
Despite technological advances, oncology drug development research has lagged in adopting wearable digital biomarkers. Explore this space's unique challenges and the benefits of wearable technology.
-
6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies
Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.
-
Veeva Vault EDC Features Brief
Delve into the details of how Veeva Vault EDC, a cutting-edge cloud-based EDC solution, enables users to design and execute their studies 50% faster with 50% less effort.
-
Why An eTMF? It's Time For A Specialized Digital Solution
Clinical trials generate reams of documents. Use an electronic trial master file to streamline much of the work of document management, logging, and compliance.
-
The Founder Behind The Platform
Learn about the founding and mission of ClinAI, a groundbreaking platform that leverages automation and analytics to enhance vendor selection and management.
-
Data Analytics For Better ClinRO Quality
Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.